Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study
Year: 2020
Type: article
Source: Blood
Authors: Hind Rafei, Hagop M. Kantarjian, Koji Sasaki, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Joseph D. Khoury, Sa A Wang, Jeffrey L. Jorgensen, Issa F. Khouri, Partow Kebriaei, Richard E. Champlin, Nitin Jain, Bouthaina S. Dabaja, Ghayas C. Issa, Naveen Pemmaraju, Tapan M. Kadia, Shilpa Paul, Nadya Jammal, Guillermo Garcia-Manero, William G. Wierda, Courtney D. DiNardo, Naval Daver, Guillermo Montalban-Bravo, Rita Khouri, Patrice Nasnas, Philip A. Thompson, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Marina Konopleva, Susan M. O'Brien, Elias Jabbour
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096051602